PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27330724-5	2016	Insulin D was only discontinued the morning of the day TCS was carried out.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	55-58	insulin	Homo sapiens	0-7	
27330724-9	2016	CONCLUSIONS: Patients can safely undergo TCS when insulin D is discontinued only once on the day of the procedure.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	41-44	insulin	Homo sapiens	50-57	
26301311-3	2015	The release of insulin from TCS particles was significantly restricted at pH 1.2 minimizing up to about < 10% in 3 hours.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	28-31	insulin	Homo sapiens	15-22